Plan debates generally return to scheduling and bans. India and The us both facial area versions of exactly the same dilemma: no matter if to impose broader, class-huge controls above fentanyl analogs as well as their precursors, or to keep material-by-compound scheduling that could lag behind traffickers’ innovation.A Daring and unapologetic sel